skip to main | skip to sidebar

The Health, Drug, Prescription, and GMP Supersite

Thoughts and resources about health, drugs and prescriptions, and how they are affected by GMPs (FDA Good Manufacturing Practices) and other regulations.

Wednesday, December 25, 2013

Merry Christmas!


Return Home: The Health, Drug, Prescription, and GMP Supersite Blog

SkillsPlus Intl Inc. - The best GMP training, best QSR training, best instructors
SkillsPlus Intl Info Blog

The Exemptee Institute
The Designated Representative Institute

The Health, Drug, Prescription, and GMP Supersite Gift Store 

Email ThisBlogThis!Share to XShare to FacebookShare to Pinterest
Posted by Austin Lee at 4:32 AM

No comments:

Post a Comment

Newer Post Older Post Home
Subscribe to: Post Comments (Atom)

From SkillsPlus International Inc.

Loading...
  • Home
  • SkillsPlus Intl Inc - The Leader in QSR & GMP Training
  • Popular FDA, cGMP, QSR, & GMP Training Courses
  • The Best Exemptee & Designated Representative Training Courses - Online Self-Study
  • CA HMDR Exemptee Certification Class
  • California Exemptee Certification - State Approved
  • The Exemptee Institute
  • The Designated Representative Institute
  • SkillsPlus Intl Inc Blog
  • Home Medical Device Retail - California HMDR Exemptee Training Certification Course
  • Designated Representative Online Training Courses

California Designated Representative Training


Designated Representative Wholesaler Training Course

Designated Representative 3PL Training Course

Designated Representative Reverse Distributor Course

SkillsPlus International Inc. is the ONLY training provider approved by the California State Board of Pharmacy to offer California Designated Representative training programs for wholesalers, 3PL, and reverse distributors. Nearly 10,000 students have taken our state license-related training courses! #2025 #2026 #2027

CA Designated Rep 3PL Course

CA Designated Rep 3PL Course
California Designated Representative 3PL Online Training Course. #2025

The Best Exemptee Training



Sign-up for Exemptee training now!


California HMDR Exemptee license online training certification class for home medical device retailers. Earns a course completion certificate accepted by the California Department of Public Health - Food and Drug Branch. We've added something new, closed captioning. Students can read what the course instructor is teaching. Nearly 10,000 students have taken our state license-related training courses! This feature helps ESL (English as a second language) students, and hard of hearing students. #2025 #2026 #2027

CGMP Online Training Courses

CGMP Online Training Courses
Current Good Manufacturing Practice Training: A New Generation Series - CGMP Online Courses

GMP Trainer Courses

GMP Trainer Courses
GMP Trainer Awareness, Certification, and Master Trainer Courses

Root Cause Analysis - cGMP Training

Root Cause Analysis - cGMP Training
cGMP Training - Online Self-Study Course - Root Cause - Investigation Reports

Subscribe To

Posts
Atom
Posts
Comments
Atom
Comments
Subscribe to The Health, Drug, Prescription, and GMP Supersite by Email

Blog List

  • NPR Blogs: Shots - Health News Blog
    RFK Jr. wants to end mental health screenings in schools. Experts say it's a bad idea
    2 hours ago
  • eLearning Industry
    Hot Off The Virtual Press: Rethink Your Course Creation Approach With AI
    2 hours ago
  • FierceBiotech
    Pharma execs cite ‘challenging’ environment during grilling by UK lawmakers over R&D pullback
    2 hours ago
  • Government Executive
    House GOP unveils 7-week stopgap funding bill, Dems say it makes shutdown more likely
    3 hours ago
  • FierceBiotech: Medtech
    Thermo Fisher debuts multiplex protein panel for neurodegenerative disease research
    3 hours ago
  • Pharmaceutical Commerce
    Communicating the Value of Approved Therapies
    4 hours ago
  • Wellness Blog - NY Times
    How Do Times Health Reporters Choose Experts?
    5 hours ago
  • GEN Biotech News
    New HEK293 Perfusion A Medium Introduced for Gene Therapy Production
    5 hours ago
  • BioPharma Dive - Latest News
    CSL nabs option to acquire a startup and its blood-clotting drug
    6 hours ago
  • BioPharma Dive
    CSL nabs option to acquire a startup and its blood-clotting drug
    6 hours ago
  • CNBC Health Care
    Eli Lilly to build $5 billion Virginia facility to boost production of targeted cancer drugs, other treatments
    6 hours ago
  • Asbestos and Mesothelioma News
    Mesothelioma Blood Test, Pre-Surgery Immunotherapy Offer Hope
    6 hours ago
  • Pharmalot – STAT
    STAT+: Pharmalittle: We’re reading about Congress and drug pricing, questions on a Sarepta drug, and more
    8 hours ago
  • Clarkston Consulting
    The Impact of Generative AI in Retail: 2025 Use Cases
    9 hours ago
  • Drug Channels
    Inside the 2025 PSAO Market: How Wholesalers Shape Pharmacy–PBM Relationships
    10 hours ago
  • Drug & Device Law
    Guest Post: It’s The “Learned” Intermediary Doctrine; Not the “Ignored” Intermediary Doctrine
    11 hours ago
  • Science-Based Medicine
    Natural History
    11 hours ago
  • All Kaiser Health News
    An HIV Outbreak in Maine Shows the Risk of Trump’s Crackdown on Homelessness and Drug Use
    12 hours ago
  • FiercePharma
    FDA targets Lilly, Novartis, BMS and more in deluge of marketing letters
    13 hours ago
  • Medtech Insight
    Morphic Medical Prepares RESET Rollout In UK And Germany, Eyes Global Expansion In 5 Years
    21 hours ago
  • FDA What's New: Drugs
    FDA Online Controlled Substances Summit, Washington, D.C. - 09/11/2025
    1 day ago
  • Medscape Today Headlines
    TRS 2025
    1 day ago
  • Healthcare Packaging
    Pharmaceutical Packaging Innovations Report Video Interview
    1 day ago
  • Marler Blog
    Lead contamination in ground cinnamon prompts FDA Warnings
    3 days ago
  • JD Supra Law News
    Part 2 Gets Teeth: HHS Empowers OCR With Enforcement Authority
    3 days ago
  • FDA - Press Releases
    FDA Launches Real-Time Adverse Event Reporting Dashboard for Cosmetic Products
    4 days ago
  • Pharmafile
    PlasmidFactory founder Dr. Martin Schleef honoured with the NRW Innovation Award 2025
    4 days ago
  • World Pharma - Breaking News
    Microbial allies: Bacteria help fight against cancer
    4 days ago
  • Food Poison Journal
    Frozen Vegetables and Fruit Recalled due to Salmonella
    4 days ago
  • The Incidental Economist
    Libraries are health hubs: why eliminate them?
    5 days ago
  • Quality Matters
    Nitrosamines: An urgent demand for vigilance and reliable testing
    1 week ago
  • Clinical Correlations
    Brewing Beneath the Surface: The Link Between Psoriasis and Cardiovascular Disease
    1 week ago
  • Pharmafile - Mfg & Production
    Rotzinger launches modular filling and capping platform for over-the-counter products
    2 weeks ago
  • Ted Eytan, MD
    Summer in the Capital
    5 weeks ago
  • Mobihealthnews
    Mendaera gets FDA 510(k) clearance for handheld robotic system
    2 months ago
  • The Compliance and Ethics Blog
    Mark Diamond on Rethinking Records Retention [Podcast]
    3 months ago
  • SkillsPlus International Info
    FDA Rushed Out AI Tool
    3 months ago
  • The Health, Drug, Prescription, and GMP Supersite
    Designated Representative Training - California | State-Approved
    3 months ago
  • Modern Healthcare News
    Meet the Administration for a Healthy America, HHS' newest agency
    3 months ago
  • Designated Representative and Exemptee
    Designated Representative Training | Board-Approved Courses | Recommended
    5 months ago
  • Pharma IQ Regulatory-Legal
    AI-Driven Productivity Gains: Transforming Pharma Supply Chain Efficiency
    6 months ago
  • FDA – Policy & Medicine
    FDA Releases Draft Guidance on the Accelerated Approval Process
    6 months ago
  • BioPharma-Reporter RSS
    Inhibikase to pause development of Parkinson’s drug
    7 months ago
  • Outsourcing-Pharma
    Ethris reports positive phase 1 results for asthma mRNA therapy
    7 months ago
  • Outsourcing-Pharma
    Ethris reports positive phase 1 results for asthma mRNA therapy
    7 months ago
  • 33 Charts
    AI and LinkedIn Writing as a Commodity
    7 months ago
  • Biotech Blog
    Making Medicines Affordable: The Role of Generics
    8 months ago
  • FDA - Health Fraud
    27 Individuals Indicted for Buying and Selling Wholesale Quantities of Misbranded and Diverted Prescription Drugs Resold to the Public Through Retail Pharmacies in Puerto Rico
    11 months ago
  • BioSpace Regulatory News
    FDA Questions Strength of Evidence Backing Zevra’s Rare Disease Therapy Ahead of Adcomm
    1 year ago
  • Healthy Travel Blog
    Hello world!
    1 year ago
  • Quality Digest - FDA Compliance
    Nine Strategies for Effective Internal Audits
    1 year ago
  • Eye on FDA
    FDA Adds New AdComm to Address Genetic Metabolic Diseases
    1 year ago
  • Designated Representative Training Courses
    The Only Board-Approved California Designated Representative Training Programs For ...
    1 year ago
  • HMDR Exemptee Online Training
    California HMDR Exemptee Online Training Certification Course
    1 year ago
  • Medgadget
    Plant-Based Soft Medical Robots
    1 year ago
  • Drug Injury Watch
    Ozempic / Wegovy: Stomach And Intestinal Problems Can Be Irreversible, Life-threatening
    2 years ago
  • Golf Foodie
    More women in the U.S. are drinking themselves to death, research finds
    2 years ago
  • PharmaPhorum News
    Patient adherence – the key to restoring trust in pharma
    2 years ago
  • Pharma Manufacturing
    How pharma can overcome inflation
    3 years ago
  • Pharmaceutical Industry | Processing & Engineering: Knowledge, News and Analysis | Pharmaceutical Manufacturing
    How pharma can overcome inflation
    3 years ago
  • CA Designated Rep Training
    Recommended! California Designated Representative Online Training Courses
    5 years ago
Show 5 Show All

Blog Archive

  • ►  2025 (1)
    • ►  June (1)
  • ►  2024 (5)
    • ►  August (1)
    • ►  July (1)
    • ►  May (1)
    • ►  March (2)
  • ►  2023 (6)
    • ►  December (1)
    • ►  October (2)
    • ►  July (1)
    • ►  May (1)
    • ►  January (1)
  • ►  2022 (26)
    • ►  November (3)
    • ►  October (1)
    • ►  August (2)
    • ►  July (3)
    • ►  June (4)
    • ►  May (3)
    • ►  April (3)
    • ►  March (1)
    • ►  February (3)
    • ►  January (3)
  • ►  2021 (17)
    • ►  December (2)
    • ►  November (2)
    • ►  October (2)
    • ►  September (2)
    • ►  July (1)
    • ►  April (1)
    • ►  March (1)
    • ►  February (2)
    • ►  January (4)
  • ►  2020 (27)
    • ►  December (5)
    • ►  November (2)
    • ►  October (1)
    • ►  September (4)
    • ►  August (2)
    • ►  July (2)
    • ►  June (2)
    • ►  May (1)
    • ►  April (1)
    • ►  March (2)
    • ►  February (5)
  • ►  2019 (28)
    • ►  December (5)
    • ►  November (2)
    • ►  October (1)
    • ►  September (2)
    • ►  August (3)
    • ►  July (6)
    • ►  June (3)
    • ►  May (2)
    • ►  April (1)
    • ►  February (3)
  • ►  2018 (6)
    • ►  October (1)
    • ►  August (1)
    • ►  July (1)
    • ►  June (1)
    • ►  May (1)
    • ►  January (1)
  • ►  2017 (14)
    • ►  November (1)
    • ►  October (2)
    • ►  August (1)
    • ►  July (1)
    • ►  May (2)
    • ►  April (1)
    • ►  March (1)
    • ►  January (5)
  • ►  2016 (32)
    • ►  December (6)
    • ►  November (4)
    • ►  October (2)
    • ►  September (2)
    • ►  August (2)
    • ►  July (3)
    • ►  June (1)
    • ►  May (3)
    • ►  March (4)
    • ►  February (2)
    • ►  January (3)
  • ►  2015 (68)
    • ►  December (2)
    • ►  November (7)
    • ►  October (10)
    • ►  September (5)
    • ►  August (1)
    • ►  July (6)
    • ►  June (7)
    • ►  May (5)
    • ►  April (3)
    • ►  March (3)
    • ►  February (13)
    • ►  January (6)
  • ►  2014 (105)
    • ►  December (10)
    • ►  November (9)
    • ►  October (1)
    • ►  September (9)
    • ►  August (4)
    • ►  July (6)
    • ►  June (11)
    • ►  May (10)
    • ►  April (10)
    • ►  March (11)
    • ►  February (15)
    • ►  January (9)
  • ▼  2013 (127)
    • ▼  December (7)
      • Merry Christmas!
      • Report: Christmas will kill you | National Monitor
      • We Moved Forward on Many Fronts This Year | FDA Voice
      • Expert Panel Want BP Cuffs Loosened - MedPage Today
      • FDA Drug Quality and Security Act Stakeholder Disc...
      • Procedure Writing Course
      • Nanotech Roundup: Latest National Nanotechnology I...
    • ►  November (14)
    • ►  October (7)
    • ►  September (11)
    • ►  August (7)
    • ►  July (9)
    • ►  June (9)
    • ►  May (6)
    • ►  April (8)
    • ►  March (22)
    • ►  February (9)
    • ►  January (18)
  • ►  2012 (172)
    • ►  December (8)
    • ►  November (20)
    • ►  October (10)
    • ►  September (8)
    • ►  August (4)
    • ►  July (22)
    • ►  June (23)
    • ►  May (17)
    • ►  April (17)
    • ►  March (12)
    • ►  February (13)
    • ►  January (18)
  • ►  2011 (116)
    • ►  December (8)
    • ►  November (15)
    • ►  October (4)
    • ►  September (18)
    • ►  August (9)
    • ►  July (6)
    • ►  June (8)
    • ►  May (9)
    • ►  April (5)
    • ►  March (13)
    • ►  February (10)
    • ►  January (11)
  • ►  2010 (106)
    • ►  December (14)
    • ►  November (8)
    • ►  October (5)
    • ►  September (6)
    • ►  August (10)
    • ►  July (5)
    • ►  June (9)
    • ►  May (11)
    • ►  April (5)
    • ►  March (11)
    • ►  February (10)
    • ►  January (12)
  • ►  2009 (192)
    • ►  December (11)
    • ►  November (11)
    • ►  October (15)
    • ►  September (13)
    • ►  August (10)
    • ►  July (19)
    • ►  June (16)
    • ►  May (16)
    • ►  April (17)
    • ►  March (16)
    • ►  February (19)
    • ►  January (29)
  • ►  2008 (245)
    • ►  December (32)
    • ►  November (39)
    • ►  October (39)
    • ►  September (33)
    • ►  August (52)
    • ►  July (50)

Disclaimer & Privacy Policy

All data and information provided on this site is for informational purposes only. Drughealth.blogspot.com makes no representations as to accuracy, completeness, currentness, suitability, or validity of any information on this site and will not be liable for any errors, omissions, or delays in this information or any losses, injuries, or damages arising from its display or use. All information is provided on an as-is basis. We use third-party advertising companies to serve ads when you visit our website. These companies may use information (not including your name, address, email address, or telephone number) about your visits to this and other websites in order to provide advertisements about goods and services of interest to you. If you would like more information about this practice and to know your choices about not having this information used by these companies, click here.

SkillsPlus International Inc.

SkillsPlus International Inc.
SkillsPlus International Inc. Logo